Bengal Physician Journal

Register      Login

VOLUME 12 , ISSUE 1 ( January-March, 2025 ) > List of Articles

CASE REPORT

Indigenous Herbal Drug (Tinospora Cordifolia) Induced Liver Injury: A Case Report

Sounak Kumar Roy, Muniruddin SK, Subham Mondal, Sandipan Mukherjee, Santa Subhra Chatterjee

Keywords : Case report, Drug induced liver injury, Giloy, Herbal induced liver injury, Tinospora cordifolia

Citation Information : Roy SK, SK M, Mondal S, Mukherjee S, Chatterjee SS. Indigenous Herbal Drug (Tinospora Cordifolia) Induced Liver Injury: A Case Report. Bengal Physician Journal 2025; 12 (1):43-45.

DOI: 10.5005/jp-journals-10070-8064

License: CC BY-NC 4.0

Published Online: 20-03-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

Drug-induced liver injury (DILI) is a condition characterized by acute or chronic liver damage following the use of hepatotoxic drugs. It can be classified based on clinical presentation (hepatocellular, cholestasis, or mixed), mechanism of hepatotoxicity, or histological appearance. Drug-induced liver injury also includes cases related to herbal-induced liver injury (HILI). Diagnosing DILI requires excluding other potential causes and identifying a consistent pattern of liver involvement. The pathogenesis typically involves the parent drug or its metabolites, which may directly impact cell biochemistry or trigger an immune response. The specific drug involved influences the pattern of liver function abnormalities, the latency period before symptom onset, the presence of immune-mediated hypersensitivity, and the response to drug discontinuation. The case discussed illustrates a DILI caused by an indigenous herbal drug, highlighting the complexities of identifying and managing liver injury in such scenarios.


HTML PDF Share
  1. Francis P, Navarro VJ. Drug-Induced Hepatotoxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. [online] Available from: https://www.statpearls.com/pharmacist/ce/activity/108826/?specialty=specialty. [Last accessed October, 2024].
  2. Fargo MV, Grogan SP, Saguil A. Evaluation of jaundice in adults. Am Fam Physician 2017;95(3):164–168. PMID: 28145671.
  3. Kapil A, Sharma S. Immunopotentiating compounds from Tinospora cordifolia. J Ethnopharmacol 1997;58(2):89–95. DOI: 10.1016/s0378-8741(97)00086-x.
  4. Kulkarni AV, Hanchanale P, Prakash V, et al. Tinospora Cordifolia (Giloy)-induced liver injury during the COVID-19 pandemic-multicenter nationwide study from India. Hepatol Commun 2022;6(6):1289–1300. DOI: 10.1002/hep4.1904.
  5. Payyappallimana U, Ravikumar K, Venkatasubramanian P. Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage?. J Ayurveda Integr Med 2023;14(1):100658. DOI: 10.1016/j.jaim.2022.100658.
  6. Kleiner DE, Chalasani NP, Lee WM, et al. Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology 2014;59(2):661–670. DOI: 10.1002/hep.26709.
  7. Kleiner DE. Drug-induced liver injury: The hepatic pathologist's approach. Gastroenterol Clin North Am 2017;46(2):273–296. DOI: 10.1016/j.gtc.2017.01.004.
  8. Fontana RJ, Bjornsson ES, Reddy R, et al. The evolving profile of idiosyncratic drug-induced liver injury. Clin Gastroenterol Hepatol 2023;21(8):2088–2099. DOI: 10.1016/j.cgh.2022.12.040.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.